Hui C. Liu

Gilead Sciences (United States) · US

Area of research

Infectious Diseases · Virology

Research interest

Research interests include HIV/AIDS drug development and treatment, HIV Research and Treatment, HIV/AIDS Research and Interventions, and HIV-related health complications and treatments.

h-index

citations

1,409

works

NIH funding

—

primary concept

—

✉ Find email ↗

Recent publications

Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate in the First Protease Inhibitor–Based Single-Tablet Regimen for Initial HIV-1 Therapy

JAIDS Journal of Acquired Immune Deficiency Syndromes 2015cited by 140position: middledoi

A Randomized Double-Blind Comparison of Coformulated Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate Versus Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate for Initial Treatment of HIV-1 Infection

JAIDS Journal of Acquired Immune Deficiency Syndromes 2013cited by 146position: middledoi

Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir versus co-formulated efavirenz, emtricitabine, and tenofovir for initial treatment of HIV-1 infection: a randomised, double-blind, phase 3 trial, analysis of results after 48 weeks

The Lancet 2012cited by 444position: middledoi

Grants

Collaborative Research: III: Medium: Empowering Graph Neural Networks from a Data Perspective

NSF2504089$300,0002025–2029PIRePORTER

NSF Rapid: Urgent sampling zooplankton for assessing ecosystem restoration of G alveston Bay after catastrophic impacts of Hurricane Harvey

NSF1760463$100,0612017–2019PIRePORTER

Design and Prototyping for Network Convergence

NSF0801997$407,0002008–2012PIRePORTER

CISE Research Instrumentation: A Broadband Software Radio Testbed for Research in Wireless Communications

NSF9818315$112,7921999–2001PIRePORTER

CAREER: Signal Processing for Software Radio Wireless Systems

NSF9896275$185,0001998–2001PIRePORTER

CAREER: Signal Processing for Software Radio Wireless Systems

NSF9703074$220,0001997–2001PIRePORTER

Frequent collaborators